Might arsenic trioxide be useful in the treatment of advanced myelodysplastic syndromes?

Saved in:

Bibliographic Details
Published in:	Haematologica (Roma) Vol. 85; no. 9; pp. 1002 - 1003
Main Authors:	DONELLI, Amedea, CHIODINO, Caterina, PANISSIDI, Tindara, RONCAGLIA, Roberto, TORELLI, Giuseppe
Format:	Journal Article
Language:	English
Published:	Pavia Haematologica 01-09-2000
Subjects:	Acute Disease Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Apoptosis - drug effects Arsenicals - pharmacology Arsenicals - therapeutic use Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Bone Marrow Cells - drug effects Cell Culture Techniques Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology Growth Inhibitors - pharmacology Growth Inhibitors - therapeutic use Humans Leukemia, Myeloid - blood Leukemia, Myeloid - drug therapy Leukemia, Myeloid - pathology Leukocytes, Mononuclear - drug effects Medical sciences Myelodysplastic Syndromes - blood Myelodysplastic Syndromes - drug therapy Myelodysplastic Syndromes - pathology Oxides - pharmacology Oxides - therapeutic use Pharmacology. Drug treatments Human Polypeptide Cytokine Cell cycle Arsenic trioxide Malignant hemopathy In vitro Biological activity Granulocyte macrophage colony stimulating factor Myelodysplastic syndrome Apoptosis
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1
ISSN:	0390-6078 1592-8721